BioMarin Pharmaceutical Market Cap

BioMarin Pharmaceutical has a market cap or net worth of €8.82 billion as of December 5, 2025. Its market cap has decreased by -21.03% in one year.

Market Cap

8.82B

Enterprise Value

8.07B

Revenue

2.64B

Ranking

n/a

PE Ratio

19.88

Stock Price

€45.98

Market Cap Chart

Since July 23, 1999, BioMarin Pharmaceutical's market cap has increased from 425.62M to 8.82B, an increase of 1,971.93%. That is a compound annual growth rate of 12.17%.

Market Cap History

Date	Market Cap	% Change
Dec 4, 2025	8.87B	-26.72%
Dec 31, 2024	12.10B	-26.36%
Dec 29, 2023	16.43B	-8.70%
Dec 30, 2022	18.00B	26.18%
Dec 31, 2021	14.26B	9.60%
Dec 31, 2020	13.01B	-3.84%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
SAP SE	242.06B
Siemens Aktiengesellschaft	175.97B
Allianz SE	141.37B
Deutsche Telekom AG	131.00B
Siemens Energy AG	98.87B
Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München	69.10B
Rheinmetall AG	68.36B
Deutsche Bank Aktiengesellschaft	59.35B

Market Cap Rankings